Jasper Fuk-Woo Chan1,2,3,4, Cyril Chik-Yan Yip2, Kah-Meng Tee2, Zheng Zhu2, Jessica Oi-Ling Tsang2, Kenn Ka-Heng Chik2, Terance Gi-Wai Tsang2, Chris Chung-Sing Chan2, Vincent Kwok-Man Poon2, Siddharth Sridhar2, Feifei Yin5, Ivan Fan-Ngai Hung3,6, Sandy Ka-Yee Chau7, Anna Jinxia Zhang2, Kwok-Hung Chan2, Kwok-Yung Yuen1,2,3,4,8. 1. State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China. 2. Department of Microbiology, The University of Hong Kong, Hong Kong, China. 3. Research Centre of Infection and Immunology, The University of Hong Kong, Hong Kong, China. 4. Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong, China. 5. Key Laboratory of Tropical Diseases and Translational Medicine, Hainan Medical University, Haikou, China. 6. Department of Medicine, The University of Hong Kong, Hong Kong, China. 7. Department of Pathology, United Christian Hospital, Hong Kong, China. 8. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong, China.
Abstract
OBJECTIVE AND METHOD: We developed and evaluated five novel real-time RT-PCR assays targeting conserved regions in the 5'-untranslated region (5'-UTR), envelope (E'), non-structural protein 2A (NS2A), NS5 and 3'-UTR of the ZIKV genome. RESULTS: The ZIKV-5'-UTR assay exhibited the lowest in vitro limit of detection (5-10 RNA copies/reaction and 3.0 × 10-1 plaque-forming units/ml). Compared to the modified version of a widely adopted RT-PCR assay targeting the ZIKV-E gene, the ZIKV-5'-UTR assay showed better sensitivity in human clinical specimens, and representative mouse specimens, including many organs which are known to be involved in human ZIKV infection but difficult to obtain in clinical settings. The ZIKV-5'-UTR assay detected ZIKV RNA in 84/84 (100.0%) ZIKV-E'-positive and an additional 30/296 (10.1%, P < 0.01) ZIKV-E'-negative mouse specimens. The higher sensitivity of the ZIKV-5'-UTR assay was most significant in kidney and testis/epididymis specimens (P < 0.01). No in vitro or in vivo cross-reactivity was found between the ZIKV-5'-UTR assay and dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus, hepatitis C virus and Chikungunya virus. CONCLUSIONS: The highly sensitive and specific ZIKV-5'-UTR assay may help to improve the laboratory diagnosis of ZIKV infection.
OBJECTIVE AND METHOD: We developed and evaluated five novel real-time RT-PCR assays targeting conserved regions in the 5'-untranslated region (5'-UTR), envelope (E'), non-structural protein 2A (NS2A), NS5 and 3'-UTR of the ZIKV genome. RESULTS: The ZIKV-5'-UTR assay exhibited the lowest in vitro limit of detection (5-10 RNA copies/reaction and 3.0 × 10-1 plaque-forming units/ml). Compared to the modified version of a widely adopted RT-PCR assay targeting the ZIKV-E gene, the ZIKV-5'-UTR assay showed better sensitivity in human clinical specimens, and representative mouse specimens, including many organs which are known to be involved in humanZIKV infection but difficult to obtain in clinical settings. The ZIKV-5'-UTR assay detected ZIKV RNA in 84/84 (100.0%) ZIKV-E'-positive and an additional 30/296 (10.1%, P < 0.01) ZIKV-E'-negative mouse specimens. The higher sensitivity of the ZIKV-5'-UTR assay was most significant in kidney and testis/epididymis specimens (P < 0.01). No in vitro or in vivo cross-reactivity was found between the ZIKV-5'-UTR assay and dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus, hepatitis C virus and Chikungunya virus. CONCLUSIONS: The highly sensitive and specific ZIKV-5'-UTR assay may help to improve the laboratory diagnosis of ZIKV infection.
Authors: Michela Mazzon; Ana Maria Ortega-Prieto; Douglas Imrie; Christin Luft; Lena Hess; Stephanie Czieso; Joe Grove; Jessica Katy Skelton; Laura Farleigh; Joachim J Bugert; Edward Wright; Nigel Temperton; Richard Angell; Sally Oxenford; Michael Jacobs; Robin Ketteler; Marcus Dorner; Mark Marsh Journal: Viruses Date: 2019-02-20 Impact factor: 5.048
Authors: William G Valiant; Mary J Mattapallil; Stephen Higgs; Yan-Jang S Huang; Dana L Vanlandingham; Mark G Lewis; Joseph J Mattapallil Journal: Sci Rep Date: 2019-05-27 Impact factor: 4.379
Authors: Jean Pierre Schatzmann Peron; Cybele C Garcia; Francisco J Quintana; Federico Giovannoni; Irene Bosch; Carolina Manganeli Polonio; María F Torti; Michael A Wheeler; Zhaorong Li; Leonardo Romorini; María S Rodriguez Varela; Veit Rothhammer; Andreia Barroso; Emily C Tjon; Liliana M Sanmarco; Maisa C Takenaka; Seyed Mohamad Sadegh Modaresi; Cristina Gutiérrez-Vázquez; Nágela Ghabdan Zanluqui; Nilton Barreto Dos Santos; Carolina Demarchi Munhoz; Zhongyan Wang; Elsa B Damonte; David Sherr; Lee Gehrke Journal: Nat Neurosci Date: 2020-07-20 Impact factor: 24.884
Authors: C J Reynolds; O M Suleyman; A M Ortega-Prieto; J K Skelton; P Bonnesoeur; A Blohm; V Carregaro; J S Silva; E A James; B Maillère; M Dorner; R J Boyton; D M Altmann Journal: Sci Rep Date: 2018-01-12 Impact factor: 4.379